A Nanorobotics-Based Approach of Breast Cancer in the Nanotechnology Era

Anca-Narcisa Neagu,Taniya Jayaweera,Krishan Weraduwage,Costel C. Darie

DOI: https://doi.org/10.3390/ijms25094981

IF: 5.6

2024-05-03

International Journal of Molecular Sciences

Abstract:We are living in an era of advanced nanoscience and nanotechnology. Numerous nanomaterials, culminating in nanorobots, have demonstrated ingenious applications in biomedicine, including breast cancer (BC) nano-theranostics. To solve the complicated problem of BC heterogeneity, non-targeted drug distribution, invasive diagnostics or surgery, resistance to classic onco-therapies and real-time monitoring of tumors, nanorobots are designed to perform multiple tasks at a small scale, even at the organelles or molecular level. Over the last few years, most nanorobots have been bioengineered as biomimetic and biocompatible nano(bio)structures, resembling different organisms and cells, such as urchin, spider, octopus, fish, spermatozoon, flagellar bacterium or helicoidal cyanobacterium. In this review, readers will be able to deepen their knowledge of the structure, behavior and role of several types of nanorobots, among other nanomaterials, in BC theranostics. We summarized here the characteristics of many functionalized nanodevices designed to counteract the main neoplastic hallmark features of BC, from sustaining proliferation and evading anti-growth signaling and resisting programmed cell death to inducing angiogenesis, activating invasion and metastasis, preventing genomic instability, avoiding immune destruction and deregulating autophagy. Most of these nanorobots function as targeted and self-propelled smart nano-carriers or nano-drug delivery systems (nano-DDSs), enhancing the efficiency and safety of chemo-, radio- or photodynamic therapy, or the current imagistic techniques used in BC diagnosis. Most of these nanorobots have been tested in vitro, using various BC cell lines, as well as in vivo, mainly based on mice models. We are still waiting for nanorobots that are low-cost, as well as for a wider transition of these favorable effects from laboratory to clinical practice.

biochemistry & molecular biology,chemistry, multidisciplinary

What problem does this paper attempt to address?

This paper attempts to solve several key problems in breast cancer treatment, which include:

1. **Breast cancer heterogeneity**: Breast cancer is a highly heterogeneous disease. Tumor cells in different patients have significant differences in genotype and phenotype, which leads to inconsistent treatment effects and the necessity of individualized treatment.

2. **Distribution of non - targeted drugs**: Traditional chemotherapy drugs are widely distributed in the body. They not only act on tumor cells but also harm normal cells, resulting in a series of side effects.

3. **Invasive diagnosis or surgery**: Traditional breast cancer diagnosis methods such as biopsy are somewhat invasive, and surgical treatment may cause damage to the patient's body functions.

4. **Resistance to classical anti - cancer therapies**: Some breast cancer cells are resistant to existing treatment methods such as chemotherapy and radiotherapy, which greatly reduces the treatment effect.

5. **Real - time monitoring of tumors**: At present, there is a lack of effective means to monitor tumor changes in real - time during the treatment process, which is crucial for adjusting the treatment plan.

In order to solve the above problems, the paper proposes to use nanorobot technology for the diagnosis and treatment of breast cancer. Nanorobots are designed to perform multiple tasks, such as targeted drug delivery, minimally invasive diagnosis and treatment, and real - time monitoring of tumor changes. These nanorobots can operate at the cellular or even molecular level, improving the accuracy and safety of treatment. Specifically, nanorobots can:

- **Targeted drug delivery**: By designing specific targeting mechanisms, nanorobots can directly deliver drugs to tumor cells, reducing the impact on normal cells and thus reducing side effects.
- **Minimally invasive diagnosis**: Nanorobots can enter the human body for non - invasive or minimally invasive diagnosis, reducing harm to patients.
- **Overcoming drug resistance**: Some nanorobots have designed multi - mode treatment strategies, such as combining chemotherapy and photodynamic therapy, to overcome the drug resistance of tumor cells.
- **Real - time monitoring**: Nanorobots can carry sensors to monitor tumor changes in real - time during the treatment process and provide timely feedback information for doctors.

In conclusion, this paper aims to solve multiple complex problems in breast cancer treatment through nanorobot technology and improve the treatment effect and the quality of life of patients.